Croda Beauty

Activities: Ingredients

Trending Articles

  1. ICROM has acquired HOLODIAG ICROM srl, an italian API CDMO, has acquired the French-based Contract Research Organization HOLODIAG sas specialized in solid state studies and crystallization services of...
  2. Lonza completes Visp microbial manufacturing facility expansion The company now hosts two 4,000L fermenters on its cGMP-compliant site, which was expanded due to the growing industry demand for biologics
  3. At CPHI Milan, TekniPlex Healthcare to Highlight New Solutions for Single-use Bioprocessing, Cell & Gene Therapies Company also will provide live demos of next-generation automatic filler-sealer for single-dose plastic vials, and showcase sustainability-minded blister packaging, as well as...
  4. PolTREG's Treg cell therapy exhibits long-term clinical remission in type 1 diabetes patients The clinical-stage biotech's lead candidate, PTG-007, has demonstrated its ability to induce clinical remission in T1D patients for up to 12 years
  5. Vetter manufactures first 100 clinical vial batches at its Austria site The CDMO has successfully completed the production of 100 liquid and lyophilised clinical batches for global clients

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Distribution

CPHI Annual Report: Building a more resilient supply chain for excipients

Ahead of CPHI, which is back in Frankfurt this year from 1–3 November with visitor numbers expected to meet or exceed prepandemic levels, Iain Moore, Head of Global Quality Assurance, Croda International, and EXCiPACT co-ordinator, discusses supply chain disruptions in the excipient industry and the positive impact of it moving forward
Finance

Croda announces new pharma business

The excipient and pharmaceutical formulation specialist has announced that its Health Care division will now become Croda Pharma after Avanti Polar Lipids acquisition
Manufacturing

Developments in global pharmaceutical excipients in the next 3–5 years: part II

Key themes that will shape the excipient landscape in the near future will include regulations, innovation, economics and sustainability, says Dr Iain Moore, Head of Global Quality Assurance, Croda International, in this year’s <i>CPhI Annual Report</i>
Manufacturing

Developments in global pharmaceutical excipients in the next 3–5 years: part I

Key themes that will shape the excipient landscape in the near future will include regulations, innovation, economics and sustainability, says Dr Iain Moore, Head of Global Quality Assurance, Croda International, in this year’s <i>CPhI Annual Report</i>
Research & Development

Croda working with partners on development of COVID-19 vaccination

During the emergence of the pandemic, Croda has actively reached out to research groups around the world, offering free of charge material and expertise.
Manufacturing

Both Croda’s US sites receive GMP certification for excipients

The scope covers alkyloxylates, esters, super refined oils and polyethylene glycol (PEG)
Research & Development

Business collaborations with universities to boost chemical industry

Croda held a technology exchange with universities to establish connections and help innovation in UK universities
Subscribe now